Alev Koçkar

Dr. Alev Koçkar

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Beyoglu Eye Journal
Verified
Journal Article
Open access
AKAlev Koçkar
Alev Koçkar
SASezgin Ak
Sezgin Ak
KOKo
Ko
ULUtku Limon
Utku Limon
EKEsra Kardes
Esra Kardes
DODo
Do
To evaluate and compare the effects of hybrid contact lenses (HCLs) and mini-scleral contact lenses (MSCLs) on visual acuity, spherical equivalent, topographic astigmatism, and higher-order aberrations (HOAs) in eyes with advanced keratoconus. We reviewed the medical records of 43 eyes of 27 patients diagnosed with advanced keratoconus fit hybrid contact lenses (AirFlex®) and mini-scleral contact lenses (Mini-misa®). Pre-fitting examinations included best corrected visual acuity (BCVA), spherical equivalent, topographic findings (topographic astigmatism, maximum keratometry, mean keratometry, central corneal thickness, thinnest corneal thickness, and corneal HOAs. Post-fitting examinations included lens corrected visual acuity, spherical equivalent, topographic astigmatism, corneal HOAs, and contact lens-related discomfort symptoms. Mean BCVA (log MAR) improved significantly from 0.65±0.27 to 0.14±0.09 with HCL and 0.58±0.25 to 0.15±0.13 with MSCL (p<0.05). The mean spherical equivalent and topographic astigmatism measurements decreased significantly in both groups (p<0.05). Eight patients in the HCL group experienced lens-related discomfort. Root-mean square HOA decreased significantly in both groups (p<0.05). Significant improvements in visual acuity, spherical equivalent, topographic astigmatism, and HOAs were observed with both lenses. However, higher patient comfort with scleral lenses may lead to higher compliance in patients with advanced keratoconus.

24 November 2025 in Strabismus
Verified
Journal Article
Closed access
AKAlev Koçkar
Alev Koçkar
AYAslı Çetinkaya Yaprak
Aslı Çetinkaya Yaprak
SDSezgi Nur Dogan
Sezgi Nur Dogan
OÖOzan Özgül
Ozan Özgül
To evaluate the long-term efficacy of botulinum toxin A (BoNT-A) in children with acute acquired comitant esotropia (AACE). This retrospective study included pediatric patients treated with BoNT-A for AACE between January 2021 and September 2024. Deviation angles at near (40 cm) and distance (5 m) were recorded before treatment and at 1, 3, 6, 12 months, and final follow-up. Outcomes were categorized as successful (≤10 prism diopters [PD]), partially successful (11-20 PD), or unsuccessful ( >20 PD). Twenty patients (mean age 5 ± 1 years; 65% female) were included. BoNT-A was administered a mean of 4 ± 2 weeks after symptom onset. A second injection was required in 35% of patients. At final follow-up (mean: 20.4 ± 12.0 months), mean near and distance deviations were 8 ± 17 PD and 10 ± 17 PD, respectively. Thirteen patients (65%) had successful outcomes, four (20%) were partially successful, and three (15%) were unsuccessful. Patients receiving a single injection had significantly better outcomes than those requiring a second (p = .041). Mild, self-resolving ptosis occurred in two cases (10%). Early treatment with BoNT-A provides a high rate of motor alignment in pediatric AACE and may reduce the need for surgery. These results support its use as an effective first-line treatment option.

17 September 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
AKAlev Koçkar
Alev Koçkar
RGRaziye Dönmez Gün
Raziye Dönmez Gün
OTOnur Temizsoylu
Onur Temizsoylu
ESElvan Alper Sengul
Elvan Alper Sengul
İAİbrahim Alataş
İbrahim Alataş
EYErdal Yüzbaşıoğlu
Erdal Yüzbaşıoğlu

2 June 2025 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
SUSıla Atamyıldız Uçar
Sıla Atamyıldız Uçar
ETEray Tunce
Eray Tunce
AKAlev Koçkar
Alev Koçkar
EKEsra Kardeş
Esra Kardeş
BSBetul Sozeri
Betul Sozeri
Objective: To evaluate the timing of uveitis onset in patients with oligoarticular juvenile idiopathic arthritis (oJIA) and to identify clinical characteristics associated with its development. Methods: This medical records review study included 611 oJIA patients followed for at least 6 months between August 2016 and February 2024. Patients were classified as with uveitis (n = 96, 15.7%) or without uveitis (n = 515, 84.3%). Uveitis cases were further stratified by timing: group 1 (n = 65, 10.6%) developed uveitis after arthritis onset, whereas group 2 (n = 31, 5.1%) were diagnosed with uveitis at their first ophthalmologic evaluation. Demographics, clinical features, and treatment characteristics were compared across groups. Results: Uveitis occurred in 15.7% of oJIA patients. Patients with uveitis had a significantly younger age at arthritis onset with a median of 4.3 years (interquartile range [IQR], 1.9–9.3 years), compared with those without uveitis (8.5 years; IQR, 5–11.5 years) (p < 0.001), and had a higher antinuclear antibody positivity rate (70.8% vs. 45.6%, p < 0.001). Methotrexate was the predominant initial treatment for oJIA, and the median duration of usage was 13 months (IQR, 6.8–26 months) until the onset of uveitis. Among the 81 patients who received etanercept as their initial biologic, 14 (17.3%) developed uveitis during the follow-up period. A total of 25 patients (26%) had ocular complications, with a significantly higher proportion observed in those with uveitis at their initial examination (n = 14, 45.1%) compared with those who develop uveitis after arthritis onset (n = 11, 16.9%) (p = 0.003). Conclusion: Our study highlights younger age at oJIA diagnosis and antinuclear antibody positivity as significant risk factors for uveitis development. Uveitis in oJIA may occur before, concurrently with or after arthritis onset. Early recognition, routine screening, and timely therapeutic escalations are essential to improve outcomes in patients with oJIA-associated uveitis.

20 February 2023 in Hitit Medical Journal
Verified
Journal Article
Closed access
AKAlev Koçkar
Alev Koçkar
HYHayati Yilmaz
Hayati Yilmaz
BABetül İlkay Sezgin Akçay
Betül İlkay Sezgin Akçay
EYErdal Yüzbaşioğlu
Erdal Yüzbaşioğlu
Purpose: COVID – 19 which is still the leading health problem in the world, is not yet fully understood, therefore the study aims to investigate the posterior segment of the eye in patients with COVID – 19 using optical coherence tomography (OCT). Materials and Methods: The present study was designed prospective and cross-sectional. Patients with a positive test result of COVID – 19 and healthy controls who were older than 18 years were included in the study. Excluded from the study were the patients with any systemic comorbidity and ocular disease. The demographic and clinical data, including ocular findings and the OCT data, including hyper-reflective (HR) lesions, retinal nerve fiber layer (RNFL), ganglion cell complex (GCC), and macular thicknesses (MT) were recorded as outcomes and analyzed. Results: Twenty patients with SARS-CoV-2 and 20 healthy subjects were included in this study. There was no difference between COVID -19 patients and healthy controls in terms of the RNFL, GCC, and macular thicknesses (P > 0.05). HR lesions were detected in 18(45%) eyes of 9(45%) patients with COVID – 19 and 15(37,5%) eyes of 8(40%) healthy subjects’ retinae with no significant difference between groups (P = 0.165). Conclusions: Hyper-reflective lesions could only be retinal vessels' tangential cuts seen in OCT B-Scans. There was not enough data that could indicate posterior segment involvement of COVID – 19.

12 February 2024 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
AKAlev Koçkar
Alev Koçkar
DYDidem Dizdar Yigit
Didem Dizdar Yigit
CGCeren Gürez
Ceren Gürez
AİAslı İnal
Aslı İnal
SÇSelcen Çelik
Selcen Çelik
BGBirsen Gökyiğit
Birsen Gökyiğit